YU238259

1943733-16-1

C22H22ClN3O4S

DMSO : >= 300 mg/mL (652.24 mM)

PI3K/Akt/mTOR; Cell Cycle/DNA Damage

YU238259 is an inhibitor of homology-dependent DNA repair (HDR), used for cancer research. IC50 & Target: HDR^[1] In Vitro: YU238259 is an inhibitor of homology-dependent DNA repair, with no effect on PARP activity. YU238259 shows cytotoxicity in BRCA2-deficient cells, with a low LD₅₀ of 8.5 uM. YU238259 (0-5 uM) causes a potent, dose-dependent decrease in HDR efficiency in U2OS DR-GFP or U2OS EJ5-GFP cells, but with no effect on NHEJ frequency. YU238259 (0-10 uM) exhibits synthetic lethality with loss of frequently mutated tumor suppressors, and shows synergism with radiotherapy (IR) and DNA-damaging chemotherapy that is potentiated by BRCA2 loss^[1]. In Vivo: YU238259 (3 mg/kg, i.p.) inhibits the growth of BRCA2-deficient tumor xenografts in nude mice^[1].